Corpus Intelligence IC Memo — FRANKLIN HOSPITAL 2026-04-27 00:04 UTC
IC Memo — FRANKLIN HOSPITAL
Investment Committee Memorandum | IL | 16 beds | Grade D | EBITDA uplift $2.0M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 141321

FRANKLIN HOSPITAL

LOCATIONFRANKLIN, IL·BEDS16·AS OFApril 27, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

FRANKLIN HOSPITAL is a 16-bed community hospital in FRANKLIN, IL with $26.6M in net patient revenue and a -7.3% operating margin. The hospital serves a payer mix of 61.4% Medicare, 0.0% Medicaid, and 38.6% commercial.

Thesis: Turnaround. Our ML models identify $2.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.3% to 0.1% (+736bps).

Net Revenue HCRIS$26.6M
Current EBITDA COMPUTED$-1.9M
Operating Margin COMPUTED-7.3%
Occupancy HCRIS13.5%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS43.2%
Distress Probability MLnan%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
57
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of -7.3% places it below the state median. Among 57 size-comparable peers (8-32 beds), the median margin is -0.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-32), prioritizing same-state peers. 57 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FRANKLIN HOSPITAL (Target)IL16$26.6M-7.3%
GIBSON AREA HOSPITAL AND HEALTIL25$125.0M-6.7%
PARIS COMMUNITY HOSPITALIL25$100.7M-4.2%
SAINT JOSEPH MEMORIAL HOSPITALIL25$86.0M33.9%
WABASH GENERAL HOSPITALIL25$71.8M4.5%
HOOPESTON COMMUNITY MEMORIAL HIL22$71.5M-5.2%
CRAWFORD MEMORIAL HOSPITALIL25$67.7M2.9%
ST. FRANCIS HOSPITALIL25$61.6M17.4%
LINCOLN MEMORIAL HOSPITALIL25$61.5M14.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$559K+210bp18mo
Cost to Collect4.5%2.5%$532K+200bp12mo
Denial Rate Reduction12.0%6.5%$527K+198bp12mo
A/R Days Reduction5200.0%3800.0%$324K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$559K
Cost to Collect
$532K
Denial Rate Reduction
$527K
A/R Days Reduction
$324K
Clean Claim Rate
$17K
Total EBITDA Uplift$2.0M
Current EBITDA$-1.9M
+ RCM Uplift+$2.0M
Pro Forma EBITDA$17K
Current Margin-7.3%
Pro Forma Margin0.1%
WC Released (1x)$1.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.0M$6.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.0M$6.5M0.00x-100.0%
Bull Case9.0x11.0x$-2.7M$12.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.7M$12.3M0.00x-100.0%
Bear Case11.0x10.0x$-3.3M$-2.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.3M$-3.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 61.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 13.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 57 hospitals with 8-32 beds
  • Same-state prioritization (n=58)
  • Comp margins: P25=-6.1% / P50=-0.8% / P75=9.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.